Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05990881 · ClinicalTrials.gov registry record · Phase 3
Injection of Botulinum Toxin for Thumb Carpometacarpal Arthritis
A Phase 3 study of Carpometacarpal Sprain and Thumb Sprain, sponsored by Rhode Island Hospital.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT05990881 is a Phase 3 study of Carpometacarpal Sprain and Thumb Sprain that is actively recruiting participants, run by Rhode Island Hospital. The registered enrollment target is 50 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05990881, a Phase 3 study of Carpometacarpal Sprain and Thumb Sprain, is actively recruiting participants, sponsored by Rhode Island Hospital.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this clinical trial is to gather information on the safety and effectiveness of botulinum toxin injection (or Botox) in the treatment of thumb joint pain/arthritis. People with thumb joint pain or arthritis usually receive steroid injections to help with the pain. However, this medicine does not always work well and also carries known important side effects. There is currently no alternative to this injection medicine. This clinical trial seeks to investigate botulinum toxin as a possible alternative to steroid injection. The difference between Botox and steroid injections is that they are different medicines and work in different ways. Botox, as it is being used in this study, is not FDA-approved. It is therefore considered an investigational medicine.
Conditions Studied
Interventions
- DRUG Botulinum toxin
- DRUG Standard-of-care corticosteroid injections
Study Locations (1)
Rhode Island
- 235 Plain Street - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2023-08-27 |
| Est. Completion | 2026-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05990881
The ClinicalTrials.gov registry entry for NCT05990881 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rhode Island Hospital, which has 130 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Carpometacarpal Sprain appearing as the primary indexed condition, and to 2 interventions - of which Botulinum toxin is the first listed.
NCT05990881 reports 1 study location spanning 1 distinct geographic area - top geographies include Rhode Island.
Frequently Asked Questions
What is clinical trial NCT05990881 about?
NCT05990881 is a clinical study titled "Injection of Botulinum Toxin for Thumb Carpometacarpal Arthritis". The purpose of this clinical trial is to gather information on the safety and effectiveness of botulinum toxin injection (or Botox) in the treatment of thumb joint pain/arthritis. People with thumb joint pain or arthritis usually receive steroid injections to help with the pain. However, this medici...
What is the current status of trial NCT05990881?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 50 participants. The study started on 2023-08-27. Estimated completion is 2026-07.
What conditions does trial NCT05990881 study?
This clinical trial studies the following conditions: Carpometacarpal Sprain, Thumb Sprain, Clostridium; Botulinum.
What interventions are being tested in trial NCT05990881?
The interventions under investigation include: Botulinum toxin (DRUG), Standard-of-care corticosteroid injections (DRUG).
Who is sponsoring clinical trial NCT05990881?
This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05990881 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.